| Direct tumor damage mechanisms of photodynamic therapy. D Nowis, M Makowski, T Stokłosa, M Legat, T Issat, J Gołąb Acta Biochimica Polonica 52 (2), 339-352, 2005 | 463 | 2005 |
| Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer M Wachowska, A Muchowicz, M Firczuk, M Gabrysiak, M Winiarska, ... Molecules 16 (5), 4140-4164, 2011 | 328 | 2011 |
| Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity D Nowis, M Legat, T Grzela, J Niderla, E Wilczek, GM Wilczynski, ... Oncogene 25 (24), 3365-3374, 2006 | 234 | 2006 |
| Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 M Winiarska, J Bil, E Wilczek, GM Wilczynski, M Lekka, PJ Engelberts, ... PLoS medicine 5 (3), e64, 2008 | 158 | 2008 |
| Cardiotoxicity of the anticancer therapeutic agent bortezomib D Nowis, M Mączewski, U Mackiewicz, M Kujawa, A Ratajska, ... The American journal of pathology 176 (6), 2658-2668, 2010 | 156 | 2010 |
| The influence of photodynamic therapy on the immune response D Nowis, T Stokłosa, M Legat, T Issat, M Jakóbisiak, J Gołąb Photodiagnosis and photodynamic therapy 2 (4), 283-298, 2005 | 155 | 2005 |
| Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface–associated calreticulin AM Dudek-Perić, GB Ferreira, A Muchowicz, J Wouters, N Prada, S Martin, ... Cancer research 75 (8), 1603-1614, 2015 | 110 | 2015 |
| Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ... Cancer immunology research 6 (4), 467-480, 2018 | 95 | 2018 |
| Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice D Nowis, M Bugajski, M Winiarska, J Bil, A Szokalska, P Salwa, T Issat, ... BMC cancer 8, 1-12, 2008 | 85 | 2008 |
| Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients K Popko, E Gorska, M Wasik, A Stoklosa, R Plywaczewski, M Winiarska, ... Journal of physiology and pharmacology 58 (5), 551-561, 2007 | 83 | 2007 |
| Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice M Makowski, T Grzela, J Niderla, M Łazarczyk, P Mróz, M Kopeé, M Legat, ... Clinical Cancer Research 9 (14), 5417-5422, 2003 | 81 | 2003 |
| B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies K Bojarczuk, M Siernicka, M Dwojak, M Bobrowicz, B Pyrzynska, P Gaj, ... Leukemia 28 (5), 1163-1167, 2014 | 76 | 2014 |
| Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin K Kozar, R Kaminski, M Legat, M Kopec, D Nowis, JS Skierski, ... International journal of oncology 24 (5), 1149-1157, 2004 | 72 | 2004 |
| GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy M Firczuk, M Gabrysiak, J Barankiewicz, A Domagala, D Nowis, M Kujawa, ... Cell Death & Disease 4 (7), e741-e741, 2013 | 69 | 2013 |
| Novel antibody therapies J Golab, M Winiarska, P Parren, W Mackus, P Engelberts US Patent App. 12/739,270, 2011 | 68 | 2011 |
| Molecular mechanisms of the antitumor effects of anti-CD20 antibodies M Winiarska, E Glodkowska-Mrowka, J Bil, J Golab Front Biosci (Landmark Ed) 16 (1), 277-306, 2011 | 68 | 2011 |
| Statins impair glucose uptake in tumor cells A Malenda, A Skrobanska, T Issat, M Winiarska, J Bil, B Oleszczak, ... Neoplasia 14 (4), 311-323, 2012 | 66 | 2012 |
| The possible role of factor H in colon cancer resistance to complement attack E Wilczek, R Rzepko, D Nowis, M Legat, J Golab, M Glab, A Gorlewicz, ... International journal of cancer 122 (9), 2030-2037, 2008 | 65 | 2008 |
| HDACi–going through the mechanisms M Wanczyk, K Roszczenko, K Marcinkiewicz, K Bojarczuk, M Kowara, ... Front Biosci 16 (1), 340-359, 2011 | 61 | 2011 |
| Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity J Bil, M Winiarska, D Nowis, K Bojarczuk, A Dabrowska-Iwanicka, ... Blood, The Journal of the American Society of Hematology 115 (18), 3745-3755, 2010 | 60 | 2010 |
